Can Prednisone Cause Anemia?

Prednisone is far more often prescribed to treat anemia than to cause it, but through several indirect pathways, this common corticosteroid can contribute to low red blood cell counts. The relationship is genuinely paradoxical: the same drug used as a first-line therapy for autoimmune hemolytic anemia can, in different circumstances, promote gastrointestinal bleeding, restrict iron availability, or set the stage for infections that shut down red blood cell production. Whether prednisone helps or hinders your blood counts depends on the dose, the duration, and the underlying condition it’s being used for.

The Paradox of a Drug That Both Treats and Threatens Red Blood Cells

Before exploring how prednisone might contribute to anemia, it’s worth understanding that corticosteroids are among the most important tools doctors have for treating certain types of anemia. In autoimmune hemolytic anemia, where the immune system attacks its own red blood cells, corticosteroids are the standard first-line therapy, effective in roughly 70 to 85 percent of patients.¹ The drug works by dialing down the immune assault on red blood cells, giving the body a chance to rebuild its supply.

Prednisone also plays a role in managing Diamond-Blackfan anemia, a rare inherited condition where the bone marrow fails to produce enough red blood cells. Patient management for this disorder typically involves corticosteroids alongside transfusions and iron chelation.² And in acquired pure red cell aplasia, where the bone marrow specifically stops making red blood cell precursors, prednisone can produce rapid improvements. In one reported case, hemoglobin rose from anemic levels to normal range within just two weeks of starting prednisone.³

At a cellular level, glucocorticoids like prednisone appear to support an early-stage population of red blood cell precursors in the bone marrow, helping to maintain and expand these progenitor cells.⁴ So in many clinical scenarios, prednisone actually boosts red blood cell production rather than suppressing it. The trouble comes when side effects of the drug create problems that outweigh this benefit.

Gastrointestinal Bleeding and Slow Blood Loss

The most straightforward way prednisone can lead to anemia is through chronic gastrointestinal bleeding. Corticosteroids irritate the lining of the stomach and intestines, and over time this can produce ulcers, erosions, or outright bleeding that slowly drains your red blood cell supply. A systematic review pooling data from dozens of randomized trials found that corticosteroids increased the risk of gastrointestinal bleeding or perforation by about 40 percent compared to placebo.⁵ Among the roughly 33,000 patients across those studies, about 2.9 percent of those on corticosteroids experienced a GI bleed compared to 2 percent on placebo.

The risk isn’t evenly distributed. Hospitalized patients showed a clear and consistent increase in GI bleeding risk, while outpatients had a much lower rate of complications, with only about 0.13 percent of ambulatory patients experiencing GI bleeds across the reviewed studies.⁵ This suggests that sicker patients, or those on higher doses, face a meaningfully greater threat. And the risk persists even when researchers excluded studies where patients were also taking NSAIDs like ibuprofen, which have their own well-known stomach risks.

What makes GI bleeding particularly insidious as a cause of anemia is that it can be subtle. A slow, steady ooze from the stomach lining may not produce dramatic symptoms like vomiting blood. Instead, it shows up as dark stools you might not notice, and the anemia develops gradually over weeks or months. By the time you feel fatigued or short of breath, the blood loss may have been ongoing for a while.

Why Stomach Protection Is Underused

Doctors can prescribe proton pump inhibitors, the acid-reducing medications often known by brand names like omeprazole, to help protect the stomach lining during corticosteroid therapy. But the data on how often this actually happens are discouraging. A study of corticosteroid users found that even among those simultaneously prescribed NSAIDs, putting them at compounded risk for GI damage, only about 6 percent also received a proton pump inhibitor.⁶ Among patients older than 70 who were on both corticosteroids and NSAIDs, the rate was even lower, around 1 percent, despite that age group facing the highest risk.

If you’re taking prednisone for more than a brief course, especially alongside anti-inflammatory painkillers, asking your doctor about stomach protection is a reasonable step. The gap between what guidelines recommend and what patients actually receive in practice is wide, and it often falls to the patient to bring it up.

How Prednisone Can Lock Up Your Iron Supply

A less obvious route to anemia involves hepcidin, a hormone that acts as the body’s master regulator of iron. Iron is essential for making hemoglobin, the oxygen-carrying molecule in red blood cells. When hepcidin levels rise, iron gets trapped inside cells and can’t be shuttled into the bloodstream where it’s needed for red blood cell production. The result is a functional iron deficiency: you may have adequate iron stores in your body, but your bone marrow can’t access them.

Research in kidney transplant recipients has shown that glucocorticoid use raises hepcidin levels. The mechanism appears to involve the glucocorticoid receptor binding directly to a regulatory region of the hepcidin gene, turning up its production. In one study, urinary prednisolone excretion, a measure of how much active drug the body is processing, was independently and significantly associated with higher serum hepcidin levels, even after accounting for factors like inflammation, kidney function, and iron supplementation.⁷

The authors of that study noted that elevated hepcidin may contribute to post-transplant anemia by causing iron malabsorption and restricting iron availability to red blood cell precursors.⁷ While this particular finding was in transplant patients, the underlying biology, corticosteroids binding to hepcidin gene promoters, isn’t unique to that population. Anyone on chronic prednisone therapy could experience some degree of iron restriction through this pathway, though the research confirming this in broader patient groups remains limited.

This is a frustrating kind of anemia to diagnose because standard iron panels can look deceptively normal. Total body iron stores may register as adequate, masking the fact that iron isn’t reaching the bone marrow. If your blood counts drop while on prednisone and your doctor checks your iron levels, the hepcidin connection is worth considering, even though it’s not yet part of routine clinical workups.

When Immunosuppression Opens the Door to Infections That Attack Red Cells

Prednisone suppresses the immune system, which is the whole point when it’s prescribed for autoimmune conditions. But a dampened immune system is also vulnerable to infections it would normally handle without trouble, and some of those infections target red blood cell production directly.

Parvovirus B19 is the textbook example. In people with healthy immune systems, this virus causes a mild childhood illness known as fifth disease, with a rash and a brief dip in red blood cell production that resolves on its own. But in people who are immunocompromised, whether from prednisone, chemotherapy, or underlying disease, parvovirus B19 can invade and destroy the bone marrow cells responsible for making new red blood cells. The infection can persist for months because the weakened immune system fails to clear the virus.

Case reports have documented prolonged anemia lasting months in immunosuppressed patients with parvovirus B19 infection, where the bone marrow essentially stopped producing red blood cell precursors entirely.⁸ In one case, a child on treatment for leukemia had anemia without any detectable young red blood cells in the blood for five months. The virus was confirmed in the blood, but the immune system was unable to produce the antibodies needed to fight it off.

Parvovirus B19 is not the only pathogen that can exploit corticosteroid-induced immunosuppression to cause anemia, but it’s the most clinically important one. The practical takeaway is that if you develop unexplained anemia while on prednisone, especially if it appears suddenly and your young red blood cell count drops to nearly zero, infection should be on the list of possible explanations.

Drug Combinations That Suppress Blood Cell Production

Prednisone is rarely prescribed in isolation. Patients with rheumatoid arthritis, lupus, inflammatory bowel disease, and other chronic conditions often take prednisone alongside other medications that carry their own blood-related side effects. When these drugs interact, the risk to blood cell production can multiply.

Methotrexate, a mainstay treatment for inflammatory arthritis and several other autoimmune conditions, is known to suppress the bone marrow. A study examining factors associated with methotrexate-related bone marrow suppression found that concurrent prednisolone use was significantly more common among patients who developed this complication. In the group that experienced myelosuppression, about two-thirds were also taking prednisolone, compared to only about one in eight in the control group.⁹ NSAIDs showed an even stronger association, and many patients were on all three drugs at once.

The mechanism isn’t entirely clear. Prednisone may alter how the kidneys clear methotrexate, or the two drugs may have additive effects on the bone marrow’s ability to produce cells. Regardless of the precise mechanism, the clinical reality is that the combination carries more risk than either drug alone. If you’re on both prednisone and methotrexate, regular blood count monitoring isn’t optional; it’s the main safety net.

Dilutional Anemia and the Appearance of Low Blood Counts

Corticosteroids cause the body to retain sodium and water, which expands the volume of fluid circulating in your blood vessels. When blood volume goes up but the actual number of red blood cells stays the same, the concentration of red blood cells per unit of blood drops. On a lab report, this looks exactly like anemia, with low hemoglobin and a low hematocrit, even though no red blood cells have actually been lost or destroyed.

This phenomenon, sometimes called dilutional pseudoanemia, is well recognized in conditions like heart failure where fluid overload is common. Prednisone’s tendency to promote fluid retention means it can produce the same misleading lab picture. If your hemoglobin dips modestly after starting prednisone and you don’t have symptoms like fatigue or shortness of breath, fluid shifts rather than true anemia may be the explanation. The distinction matters because treating dilutional pseudoanemia with iron supplements or transfusions would be pointless and potentially harmful.

Your doctor can usually sort this out by looking at additional markers. True anemia from blood loss or iron restriction typically produces changes in red blood cell size and hemoglobin content that dilutional effects don’t. But the initial hemoglobin number on a routine blood test can’t tell the difference, which is why context matters.

Who Is Most Vulnerable

Not everyone on prednisone faces the same degree of risk for developing anemia. Several factors tilt the odds:

• Dose and duration: Short courses of prednisone at moderate doses, such as a five-day burst for an asthma flare, are unlikely to produce meaningful GI bleeding, significant hepcidin elevation, or dangerous immunosuppression. The risks compound with higher doses and longer treatment courses. Most of the concerning pathways described in this article become relevant after weeks to months of therapy.
• Concurrent medications: As the methotrexate data illustrate, adding prednisone to other drugs that affect the bone marrow or irritate the gut amplifies risk. NSAIDs are a particularly common co-prescription that stacks GI bleeding risk on top of corticosteroid effects.
• Underlying disease: People taking prednisone for conditions that themselves cause anemia, such as lupus, rheumatoid arthritis, or chronic kidney disease, are already starting from a compromised baseline. The drug may simultaneously treat one driver of anemia (autoimmune destruction) while contributing to another (iron restriction via hepcidin).
• Age: Older adults absorb iron less efficiently, have less physiological reserve, and are more susceptible to both GI bleeding and infection. They also tend to be on more medications, raising the likelihood of problematic interactions.

Practical Blood Monitoring on Prednisone

If you’re starting a prednisone course that will last more than a couple of weeks, a baseline complete blood count gives your doctor something to compare against later. Repeat counts at intervals your doctor recommends, often every few months for chronic use, can catch a downward trend before it becomes severe. Pay particular attention if you notice new fatigue, pale skin, increased heart rate at rest, or dark or tarry stools, all of which warrant an earlier blood draw.

When anemia does appear during prednisone therapy, the cause isn’t always obvious. Your doctor may need to check iron studies, a reticulocyte count to see whether the bone marrow is responding appropriately, and markers of hemolysis to distinguish between blood loss, impaired production, and red blood cell destruction. In patients on immunosuppressive regimens, testing for parvovirus B19 is reasonable when the reticulocyte count is unusually low.

It’s also worth reporting GI symptoms promptly rather than waiting them out. Abdominal pain, heartburn, nausea, or changes in stool color while on prednisone are not minor complaints to push through. They can be early warnings of the kind of chronic blood loss that leads to iron-deficiency anemia over time. Early intervention, whether through dose adjustment, adding stomach protection, or switching to a different corticosteroid formulation, can prevent a manageable side effect from becoming a serious one.

When Prednisone Gets Blamed for Anemia It Didn’t Cause

Because prednisone is prescribed for conditions that frequently involve anemia as a feature of the disease itself, the drug often gets blamed for blood count problems it didn’t create. Rheumatoid arthritis and lupus, two of the most common reasons for long-term prednisone use, both produce anemia of chronic inflammation through mechanisms unrelated to corticosteroid therapy. In these conditions, the inflammatory process itself drives up hepcidin and suppresses red blood cell production. Prednisone, by reducing inflammation, may actually improve this type of anemia even as it creates other risks.

Sorting out whether prednisone is helping or hurting your blood counts requires looking at the timeline. If anemia was present before starting the drug and improves afterward, the underlying disease was probably the main driver. If blood counts were normal and started falling after prednisone was introduced, the drug’s side effects deserve more scrutiny. In practice, the picture is often messy, with multiple contributing factors overlapping. A good clinician considers the whole medication list, the disease trajectory, and the specific pattern of the anemia rather than pointing to any single culprit.